
Adipose-Tissue-on-Chip: Perfused Platforms Driving Next-Gen Metabolic Research
Obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD) remain major global health concerns, yet
Obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD) remain major global health concerns, yet
Adipose tissue organoid technology is reshaping metabolic research. From scaffold-free spheroids to hydrogel-based 3D adipose tissue
What Does Adipose Tissue Do? Adipose tissue is more than a fat storage site, it’s a
As the global obesity crisis intensifies, the functional aspect of brown adipose vs white adipose tissue
Modern drug discovery is shifting from “one-size-fits-all” animal models toward new-approach methodologies (NAMs) that capture human-specific
The interplay between adipose tissue and therapeutic efficacy is now recognised as a major determinant of clinical
Spheroids, as a good universal organ model ? Recent advances in bioengineering of cells, tissue coupled
Introduction MPS (Multiorgan Microphysiological Systems) have evolved from tools to reduce animal experimentation and improve preclinical
The human body: systems, organs, and main functions The human body is composed of several different
Introduction Melanoma is clearly a complex disease with a high degree of heterogeneity and adaptability. Melanoma
14 rue de la Beaune,
93100 Montreuil (Paris)
France
+33 9 87 04 70 35
contact@cherrybiotech.com
All right reserved to © Cherry Biotech 2023